Abstract
Head-and-neck cancer (HNC) can present with life.threatening symptoms in the emergency department. Patients can sometimes be misdiagnosed with pulmonary disease due to similar signs and symptoms, ultimately leading to delayed diagnosis and potentially devastating consequences. Reasons for this include lack of awareness of patient risk factors and knowledge of the myriad of presenting complaints in the disease process among physicians working in primary care and in the emergency department. This article explores the contemporary risk factors and common presenting symptoms and discusses initial management for a patient with potential head-and-neck malignancy. Emergency presentations of HNC are wide ranging and can overlap with common respiratory pathologies. Clinician awareness of this can assist the team in deciding what appropriate examination and investigations are required to reduce the risk of delaying diagnosis and further treatment.
Keywords: Airway obstruction, emergency departments, emergency treatment, head-and-neck cancer, signs and symptoms
INTRODUCTION
Head-and-neck cancer (HNC) is the seventh most common cancer worldwide with mortality rates exceeding 50%.[1] HNC includes several different locations with a myriad of symptoms present at diagnosis making early detection challenging. Accordingly, the majority of patients with HNC are diagnosed at stage III or IV,[2] this being one of the strongest predictors of mortality.[3,4,5,6] Delayed diagnosis can be exacerbated by delays in presentation and referral from primary care as well as diagnosis and treatment in secondary care.[7] The emergency presentation of cancer is a significant burden, accounting for 24% of new diagnoses in England.[8] In HNC, around 10%–15% present via the emergency department and it translates into more advanced stage at diagnosis and worse survival outcomes.[9] Accordingly, there is a need for a better understanding of HNC presenting symptoms, so general practitioners and emergency department doctors can identify them early to improve diagnosis and prognosis.[10] This is particularly relevant when considering the increasing incidence of human papillomavirus (HPV)-related HNC that is changing the paradigm of patients with this disease.
Here, we conduct a contemporary review of the most common HNC risk factors and symptoms presenting in the emergency department and its initial management recommendations.
Risk factors for head-and-neck cancer
Knowledge of the risk factors for HNC is essential to be able to suspect this uncommon pathology. HNC is a cancer of adults, with a median age at diagnosis of 66 years for HPV-negative mucosal head-and-neck squamous cell carcinoma (HNSCC) and 53 years for HPV-positive HNSCC although it can be found in any age group. HNSCC is by enlarge the most common histological type of HNC. Therefore, we discuss its risk factors.
Smoking
Typically, HNSCC has been diagnosed in adults with a history of heavy tobacco and alcohol consumption. Tobacco causes a four- to five-fold increase in risk of developing oral cavity, oropharynx, and hypopharynx cancer alongside a 10-fold increased risk of laryngeal cancer.[11,12] Patients consuming 2 or more packets of tobacco a day in combination with alcohol have a 35-fold higher risk of developing HNSCC.[13,14] Historically, approximately 90% of patients with HNSCC had a history of tobacco use.[13] However, the incidence of HNSCC in this cohort of patients is slowly declining due to a decrease of consumption of these risk factors.[15]
Smokeless tobacco, areca nut, and betel quid
Smokeless tobacco, such as snuff or chewing tobacco, is an important HNSCC risk factor, particularly for cancers of the oral cavity.[16] There is an estimated 80% increase in risk of oral cavity cancer,[16] with a four-fold increase in odds of HNSCC among individuals who have used smokeless tobacco for at least 10 years compared to never-users.[17]
Alcohol
Alcohol independently increases the risk of HNC, with an estimated 1%–4% of cases attributable to alcohol alone,[13,18] and a two-fold increase in odds of HNSCC for drinkers who are never-users of tobacco.[19]
Human papillomavirus
HPV is a sexually transmitted infection known to be the putative precursor to HPV-related HNSCC (HPV-HNSCC), a distinct subset of HNSCC that occurs primarily in the oropharynx and arises from the lymphoid tissues of the palatine and lingual tonsils.[20] With more than 100 serotypes of HPV, only a small number of these are considered high risk or carcinogenic with most infections not progressing to cancer. HPV-16 is responsible for the vast majority of HPV-HNSCC.[21] The proportion of oropharyngeal cancers caused by HPV is growing;[22] therefore, awareness of the current epidemic of HPV-HNSCC is crucial for appropriate suspicion and early diagnosis. The average latency period of 10–30 years from initial oral infection to diagnosis of HPV oropharyngeal cancer means that risk factors may not be obvious at the moment of presenting symptoms.[23] HPV-HNSCC is more common in males and people with multiple lifetime sexual partners.[24]
Common symptoms in head-and-neck cancer
HNC includes cancers of the upper aerodigestive tract (oral cavity, nasopharynx, oropharynx, hypopharynx, and larynx), the paranasal sinuses, and the salivary glands. The anatomical sites affected are important for functions such as speech, breathing, and swallowing. Therefore, patients with HNC can manifest with impairment of those functions among other local and systemic symptoms.
Patients can present with systemic symptoms including cachexia, sarcopenia, weakness, chronic fatigue, or mood disorders among others.[25] The most common red flag symptoms encountered in the emergency department that should raise suspicion for HNC are described below. A higher level of suspicion is raised when these symptoms occur in combination and in a persistent pattern.
Airway obstruction
Airway obstruction is defined as narrowing or restriction of the airway leading to deterioration in ventilation. In relation to HNC, airway obstruction can occur due to direct extension of tumors, bilateral vocal cord palsy, or rarely, obstructive lymphedema.[26] It can be subdivided by severity (partial or complete) or chronicity (acute or chronic). In slowly progressive cancer, with conditioning of the respiratory muscles, patients may have few signs or symptoms despite significant narrowing of the airway. Good clinical history and examination are required to determine the urgency of treatment and further management. A high level of suspicion for HNC is required since it shares similar risk factors with pulmonary disease that can mimic symptoms and attribute to misdiagnosis. Symptoms pointing toward a diagnosis of airway obstruction include respiratory distress and stridor (high-pitched sound due to irregular flow of air in airways). A mild biphasic stridor can be mistaken for wheeze and can be misdiagnosed as obstructive pulmonary disease. The differential diagnosis of upper airway obstruction due to supraglottic or glottic narrowing should be kept in mind if patients do not respond to initial medical treatment [Figure 1].
Figure 1.

Airway obstruction
It is important to note that patients' oxygen saturation levels can often be unaffected during initial presentation. The cause of distress in this scenario is obstruction rather than compromised ventilation. Therefore, patients tend to maintain normal saturation levels at the expense of increasing ventilation rate and use of accessory muscles. Normal saturations can be falsely reassuring and could potentially lead to a delayed diagnosis and life-threatening upper airway obstruction. Associated symptoms that should raise the suspicion of airway obstruction rather than pulmonary disease are hoarseness, dysphagia, referred earache, weight loss, and/or neck mass. In an unstable patient with signs of respiratory distress or drooling, urgent assessment and management to ensure airway patency is mandatory. Evaluation of the airway should include an assessment of the difficulty in intubation and the feasibility of appropriate rescue plans in achieving oxygenation. Senior emergency department physicians and/or anesthetists should assess the patient for intubation to secure the airway. Besides checking for vital parameters, assessment includes evaluation of mouth opening, Mallampati test, size of mandibular space, and endoscopic examination when possible, being crucial when no radiological investigations are possible due to the time-critical nature of the situation. Awake fiberoptic intubation is the gold standard technique in this situation. The National Audit Project 4 report emphasized the importance of having an “airway management strategy” as opposed to a single plan and the timely sequential implementation of these plans for HNC.[27] Otolaryngology input is always recommended during intubation as there is a risk of requiring front-of-the-neck access. Patients can be optimized with humidified high-flow nasal oxygen while these interventions are executed.[28,29] For stable patients, consider nebulized adrenaline and intravenous steroids.
Neck mass
The primary concern of a slow-growing, persistent neck mass with no associated inflammatory signs in an adult is an underlying malignant pathology. The described pattern of lymphatic drainage is helpful in diagnosing the tumor primary site in HNC.[30] Accordingly, an accurate definition of the location of the mass, size, and other clinical features such as skin involvement, consistency of mass, and attachment to surrounding structures is mandatory. When a patient presents with a neck mass, a full detailed head-and-neck examination including skin and oral cavity is required. Patients with HPV-related cancers of the oropharynx most commonly present with a painless lateral neck mass and no other symptoms.[31] Because of the patient's young age, absence of risk factors, and unusual presentation, the symptoms might be confused with benign reactive nodal enlargement, thus delaying the diagnosis. Salivary gland tumors can also debut as a painless mass in the neck or side of the face in patients who are otherwise well. Accordingly, in all adults, a neck mass should be considered malignant until demonstrated otherwise and patients must be urgently referred to a head-and-neck specialist for further evaluation [Figure 2].
Figure 2.

Neck mass
Sore throat/throat pain
Sore throat is a common complaint with a vast differential diagnosis. From 2001 to 2002, the National Health Care Survey reported more than 21 million outpatient and emergency room visits with complaints relating to the throat.[32] By paying close attention to the associated symptoms and duration, common infectious etiologies such as viral tonsillitis or supraglottitis can be distinguished from HNC. The latter normally present with associated symptoms as described above and over a longer period of time such as weeks to months. Any sore throat that has persisted beyond 3 weeks and/or progression of sore throat with increasing pain or irritation warrants further investigation by a head-and-neck specialist. As the presenting complaint of sore throat may mean irritation, burning sensation, or frank pain, patients should be asked to elaborate on the description. Additionally, they should be asked to localize pain as it can refer to a variety of anatomical locations, for example, the entire pharynx and larynx or the soft tissues of the neck. Asking the patient to indicate the centre of discomfort in their neck can often aid in localisation of pathology. Persistent unilateral sore throat with otalgia is a frequent presenting complaint of HNC.[33,34]
Dysphagia
Dysphagia is a common symptom of complaint in the emergency department and is frequently present in patients with HNC profoundly diminishing quality of life.[35] In the emergency department, the management of these patients includes basic investigations aimed at diagnosing the cause and to understand the severity or chronicity of dysphagia. The first step is to rule out immediate life-threatening etiologies. Causes of dysphagia can be broadly classified anatomically into oropharyngeal or esophageal.[36] Acute neurological and life-threatening pathologies such as a stroke should be primarily investigated as dysphagia can be a common presenting problem. In this scenario, dysphagia is associated with other neurological symptoms such as unilateral weakness, facial drooping, or speech impairment.[37] When dysphagia is present in patients with HNC, it tends to develop progressively leading to malnutrition and dehydration as well as other local symptoms such as choking and aspiration pneumonia.[38] In contrast, these symptoms are rare in patients with esophageal causes.[36] Common findings which should raise the suspicion of HNC are the presence of a neck mass, nonhealing ulcers in the oral cavity, voice change, or cranial nerve involvement,[39] and accordingly, when present, urgent referral to an HNC specialist is recommended. Hospital admission should be considered for patients with respiratory complications or patients at high risk of malnourishment and dehydration. Patients should be kept nil by mouth and started on appropriate intravenous fluids if swallow is deemed unsafe. Odynophagia can be treated by optimizing pain relief, as discussed in the section “Pain management.” The UK HNC guidelines recommend that all patients have nutritional screening by a clinician at presentation and specialist dietician input throughout their care. The incidence of refeeding syndrome because of reintroduction of nutrients is high in HNC patients.[40] Refeeding syndrome occurs not only after starvation but also after periods of poor nutritional intake. As mentioned above, this is a common emergency presentation of HNC due to oropharyngeal dysphagia, cancer cachexia, and the high prevalence of alcoholism.[41] Refeeding syndrome is caused by hormonal and metabolic changes that lead to clinically significant hypophosphatemia, thiamine deficiency, and hypomagnesemia. Accordingly, serum electrolyte check is mandatory in the emergency department when malnourishment is suspected prior to re-instate feeding either enteral or parenteral.
Nonhealing ulcer
The association between chronic ulcer and HNSCC is well established. Its presentation, however, is varied, ranging from innocuous appearing lesions to overtly exophytic growths.[42] Although an ulcerated SCC is classically described to have prominent everted edges and a necrotic tumor base, these features are not always present, particularly in early stages of their development. For oral cancer, nonhealing ulcers or sores have been reported to be the very first symptom noted.[43] When associated with other head-and-neck symptoms or cranial nerve palsy, the suspicion for HNC should be high and urgent referral is indicated.
Unilateral recurrent epistaxis, nasal obstruction, and otalgia with normal ear examination or ear effusion
Patients with this problem should be considered for urgent referral to a head-and-neck surgeon who can do a full examination of the upper aerodigestive tract with an endoscopy to exclude nasal and postnasal space tumors.
Bleeding
Bleeding from HNC can be a life-threatening event and can occur from the tumor itself or due to the erosion of tumor into surrounding vascular structures. Carotid blowout syndrome can occur due to rupture of the carotid artery or branches caused by tumor erosion.[44] This syndrome has three distinct possible clinical presentations; a threatened blowout where there is a clinically exposed carotid artery or radiological evidence of tumor invasion of artery, an impending blowout whereby herald bleeding has settled or an acute, uncontrollable bleeding.[45] The last subgroup of patients should be escalated immediately to the anesthetic and otolaryngology team for further management. The patient should be sat upright and blood suctioned orally under direct vision to prevent any further bleeding. In the event of massive hemorrhage, the patient should be resuscitated and given blood products. Definitive management will depend on airway assessment; in severe cases, patients would require endotracheal intubation or front-of-the-neck access to secure the airway followed by surgical intervention or interventional radiology taking into consideration resources available at the hospital.
Management plan in the emergency department
Assessment
ABCDE approach is widely recognized and adapted in clinical practice for initial assessment of acutely unwell patients.[46] Assessment aims to identify and treat patients' most life-threatening problems first. In symptoms associated with HNC, this can often involve risk to the airway and breathing as described above. With patients presenting with any of the symptoms described, a full head-and-neck examination including skin and oral cavity and endoscopic examination when possible are required.
What tests are necessary?
Blood tests
Following thorough history and examination, blood tests such as full blood count, urea, electrolytes, renal function, C-reactive protein, and coagulation screen provide information on presenting complaints and potential complications. For example, patients with dysphagia can also present with raised infection markers secondary to aspiration pneumonia. Arterial blood gas gives indication to any ventilatory compromise and need for oxygen therapy. Urea, renal function, and electrolytes can provide information around degree of malnourishment and dehydration that the patient is presenting with.
Imaging
Imaging provides an indication of cause of symptoms and can aid in assessing patients' airway. In HNC, imaging can provide valuable information to diagnose potential complications and to rule out other pathologies causing symptoms. A chest X-ray in patients with respiratory distress and wheeze can indicate if the patient has chronic obstructive pulmonary disease (COPD) or aspiration pneumonia. As mentioned in the section “Airway obstruction,” HNC can be misdiagnosed with lower respiratory disease such as COPD which shares the same risk factors and is important to consider HNC in this situation. Accordingly, neck cross-sectional imaging can not only provide information about tumor extent and size, nodal disease, and tumor spread when HNC is confirmed but also diagnose the etiology when it is not clear on examination.
Endoscopy
When HNC is suspected, flexible nasal endoscopy can be performed to investigate the nasal cavity, pharynx, and larynx to provide further information on presenting complaints. Patients with symptoms of potential airway obstruction should undergo examination to inform further management, for example, impending airway obstruction which might require airway management with intubation or a tracheostomy. Patients presenting with oral bleeding with suspected HNC should undergo this procedure to determine where bleeding point is.
Pain management
In suspected HNC patients, the disease process can lead to unmanageable pain that can result in malnutrition[47] and negative psychological impact[48,49] leading to disengagement with service and treatments. It is imperative to assess and treat symptoms to prevent further deterioration of quality of life. Patients with HNC report a high prevalence of pain at 70%, with 48% of patients having pain as a presenting complaint.[50] Cancer pain can be classified into nociceptive or neuropathic pain and can arise from multiple etiologies such as tumor destruction of local tissues and nerves or because of previous treatments for example surgery or radiotherapy.[51] The World Health Organization (WHO) published updated guidelines on managing cancer pain in adults and adolescents in 2019 providing a framework for clinicians to manage cancer pain optimally.[52] Guiding principles can be adapted to managing patients with suspected head-and-neck pathology.
Pain management has shifted from general application of the WHO analgesic ladder to more individualized strategies considering patients' clinical situation, pain intensity, and availability of drugs.[53] Treatment of pain should be multi-modal and can be initiated with nonopioid analgesics such as nonsteroidal anti-inflammatory drugs as a monotherapy or in combination with weak and/or strong opioids for moderate-to-severe pain. Patients presenting with concomitant dysphagia might require alternatives to oral route such as intravenous and transdermal administration of pain medication.[54] Furthermore, patients can also present with neuropathic pain secondary to cranial nerve involvement, and these patients can benefit from neuropathic agents such as antidepressants[55,56] (tricyclic antidepressants) and anticonvulsants[57] (gabapentin). The summary of types of maintenance and adjuvant pharmacological treatment and typical starting dose are listed in Table 1.
Table 1.
Classes of medications and suggested recommended dose for managing pain in adults
| Medicine group | Class | Examples |
|---|---|---|
| Nonopioids | Paracetamol NSAIDs |
Tablets, liquid, rectal suppositories, injectable Ibuprofen - tablets, liquid Ketorolac - tablets, injectable |
| Opioids | Weak opioids Strong opioids |
Codeine - oral tablets, liquid Morphine - tablets, liquid Fentanyl - injectable, transdermal patch, transmucosal lozenges |
| Adjuvants | Steroids Antidepressants Anticonvulsants |
Dexamethasone - tablets, injectable Methylprednisolone - tablets, injectables Amitriptyline and venlafaxine - oral tablets Carbamazepine - oral tablets, injectables |
|
| ||
| Medicine | Typical starting dose | Notes |
|
| ||
| Paracetamol | 500–1000 mg orally/intravenously every 6 h | Maximum of 4 g/24 h (in individuals with body weight>50 kg) |
| Ibuprofen | 400–800 mg orally every 8 h | Take with food and/or protein pump inhibitor. Maximum dose 2.4 g/24 h |
| Morphine | 5 mg orally every 4 h 2 mg intravenous/subcutaneous every 4 h |
No maximum dose |
| Fentanyl | 12–25 μg/h transdermal patch every 72 h | No maximum dose |
| Amitriptyline | 10–25 mg orally at bedtime | Maximum dose 100 mg/24 h |
Adapted from WHO. WHO: World Health Organization, NSAIDs: Nonsteroidal anti-inflammatory drugs
What recommendations should be given/referrals?
The NICE guidelines[58] recommend urgent referral when the patient suffers from persistent unexplained hoarseness, unexplained lump in the neck, persistent ulceration, a mass, or abnormal bleeding in the oral cavity, or a red and white patch in the oral cavity consistent with erythroplakia or erythroleukoplakia.
Increased awareness of the disease not only among patients but also clinicians is crucial for improving the rate of early diagnosis and therefore the survival outcomes.[59] So far, no strong evidence supports visual examination or other screening methods in the general population. There is no available screening for HNC or HPV, and HPV vaccination is not widely approved internationally for prevention of oropharyngeal cancer. However, it has gained the US Food and Drug Administration approval for prevention of oropharyngeal and other HNCs.[60] Evidence shows that the risk of HNC decreases with increasing time since smoking cessation.[61,62] Clinicians should be aware of associated risk factors of HNC, and information can be gathered through detailed history taking and to provide advice where appropriate to support primary prevention.
CONCLUSION
HNC can result in severe consequences when not recognized. Patients present with a myriad of symptoms possibly causing a delay in diagnosis. Emergency presentation is not infrequent and general practitioners and emergency doctors should be aware of the most common presenting symptoms and its appropriate management as described above. Special attention should be taken when patients present with a combination of the above-mentioned most common presenting symptoms.
Key points
HNC presents with a variety of symptoms that can be seen in the emergency department and primary care
Risk factors may not be obvious on presentation, but it is essential to be aware of them during initial assessment of patients
The incidence of HPV-HNC is increasing modifying the paradigm of patients with HNC to younger and healthier individuals without the classic common risk factors
Thorough history of presenting complaints, associated symptoms, chronicity, and systemic features is essential for diagnosis and management of the HNC
Ventilation compromise might not be clinically obvious due to compensatory mechanisms, but airway obstruction secondary to HNC can result in rapid deterioration.
Research quality and ethics statement
The authors followed applicable EQUATOR Network (https://www.equator-network.org/) guidelines, notably the CARE guideline, during the conduct of this review.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
REFERENCES
- 1.Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. doi: 10.3322/caac.21492. [DOI] [PubMed] [Google Scholar]
- 2.Chow LQM. Head and neck cancer. N Engl J Med. 2020;382:60–72. doi: 10.1056/NEJMra1715715. [DOI] [PubMed] [Google Scholar]
- 3.Giraldi L, Leoncini E, Pastorino R, Wünsch-Filho V, de Carvalho M, Lopez R, et al. Alcohol and cigarette consumption predict mortality in patients with head and neck cancer: A pooled analysis within the international head and neck cancer epidemiology (INHANCE) consortium. Ann Oncol. 2017;28:2843–51. doi: 10.1093/annonc/mdx486. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP. Trends in incidence and prognosis for head and neck cancer in the United States: A site-specific analysis of the SEER database. Int J Cancer. 2005;114:806–16. doi: 10.1002/ijc.20740. [DOI] [PubMed] [Google Scholar]
- 5.Stanford-Moore G, Bradshaw PT, Weissler MC, Zevallos JP, Brennan P, Anantharaman D, et al. Interaction between known risk factors for head and neck cancer and socioeconomic status: The Carolina head and neck cancer study. Cancer Causes Control. 2018;29:863–73. doi: 10.1007/s10552-018-1062-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Schutte HW, Heutink F, Wellenstein DJ, van den Broek GB, van den Hoogen FJ, Marres HA, et al. Impact of time to diagnosis and treatment in head and neck cancer: A systematic review. Otolaryngol Head Neck Surg. 2020;162:446–57. doi: 10.1177/0194599820906387. [DOI] [PubMed] [Google Scholar]
- 7.Swann R, McPhail S, Witt J, Shand B, Abel GA, Hiom S, et al. Diagnosing cancer in primary care: Results from the national cancer diagnosis audit. Br J Gen Pract. 2018;68:e63–72. doi: 10.3399/bjgp17X694169. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Bannister M, Ah-See KW. Is oropharyngeal cancer being misdiagnosed as acute tonsillitis? Br J Gen Pract. 2014;64:e742–4. doi: 10.3399/bjgp14X682537. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Rovira A, Russell B, Trivedi P, Ojo O, Oakley R, Byrne E, et al. The impact of 2 weeks wait referral on survival of head and neck cancer patients. Eur Arch Otorhinolaryngol. 2023;280:5557–64. doi: 10.1007/s00405-023-08152-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Bannister M, Vallamkondu V, Ah-See KW. Emergency presentations of head and neck cancer: A modern perspective. J Laryngol Otol. 2016;130:571–4. doi: 10.1017/S0022215116001043. [DOI] [PubMed] [Google Scholar]
- 11.Vineis P, Alavanja M, Buffler P, Fontham E, Franceschi S, Gao YT, et al. Tobacco and cancer: Recent epidemiological evidence. J Natl Cancer Inst. 2004;96:99–106. doi: 10.1093/jnci/djh014. [DOI] [PubMed] [Google Scholar]
- 12.Rettig EM, D'Souza G. Epidemiology of head and neck cancer. Surg Oncol Clin N Am. 2015;24:379–96. doi: 10.1016/j.soc.2015.03.001. [DOI] [PubMed] [Google Scholar]
- 13.Hashibe M, Brennan P, Benhamou S, Castellsague X, Chen C, Curado MP, et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: Pooled analysis in the international head and neck cancer epidemiology consortium. J Natl Cancer Inst. 2007;99:777–89. doi: 10.1093/jnci/djk179. [DOI] [PubMed] [Google Scholar]
- 14.Blot WJ, McLaughlin JK, Winn DM, Austin DF, Greenberg RS, Preston-Martin S, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res. 1988;48:3282–7. [PubMed] [Google Scholar]
- 15.Mourad M, Jetmore T, Jategaonkar AA, Moubayed S, Moshier E, Urken ML. Epidemiological trends of head and neck cancer in the United States: A SEER population study. J Oral Maxillofac Surg. 2017;75:2562–72. doi: 10.1016/j.joms.2017.05.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Secretan B, Straif K, Baan R, Grosse Y, El Ghissassi F, Bouvard V, et al. A review of human carcinogens – Part E: Tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol. 2009;10:1033–4. doi: 10.1016/s1470-2045(09)70326-2. [DOI] [PubMed] [Google Scholar]
- 17.Zhou J, Michaud DS, Langevin SM, McClean MD, Eliot M, Kelsey KT. Smokeless tobacco and risk of head and neck cancer: Evidence from a case-control study in New England. Int J Cancer. 2013;132:1911–7. doi: 10.1002/ijc.27839. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Anantharaman D, Marron M, Lagiou P, Samoli E, Ahrens W, Pohlabeln H, et al. Population attributable risk of tobacco and alcohol for upper aerodigestive tract cancer. Oral Oncol. 2011;47:725–31. doi: 10.1016/j.oraloncology.2011.05.004. [DOI] [PubMed] [Google Scholar]
- 19.Hashibe M, Boffetta P, Zaridze D, Shangina O, Szeszenia-Dabrowska N, Mates D, et al. Contribution of tobacco and alcohol to the high rates of squamous cell carcinoma of the supraglottis and glottis in central Europe. Am J Epidemiol. 2007;165:814–20. doi: 10.1093/aje/kwk066. [DOI] [PubMed] [Google Scholar]
- 20.Begum S, Cao D, Gillison M, Zahurak M, Westra WH. Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma. Clin Cancer Res. 2005;11:5694–9. doi: 10.1158/1078-0432.CCR-05-0587. [DOI] [PubMed] [Google Scholar]
- 21.Gillison ML, Alemany L, Snijders PJ, Chaturvedi A, Steinberg BM, Schwartz S, et al. Human papillomavirus and diseases of the upper airway: Head and neck cancer and respiratory papillomatosis. Vaccine. 2012;30(Suppl 5):F34–54. doi: 10.1016/j.vaccine.2012.05.070. [DOI] [PubMed] [Google Scholar]
- 22.Menezes FD, Fernandes GA, Antunes JL, Villa LL, Toporcov TN. Global incidence trends in head and neck cancer for HPV-related and -unrelated subsites: A systematic review of population-based studies. Oral Oncol. 2021;115:105177. doi: 10.1016/j.oraloncology.2020.105177. [DOI] [PubMed] [Google Scholar]
- 23.Taberna M, Mena M, Pavón MA, Alemany L, Gillison ML, Mesía R. Human papillomavirus-related oropharyngeal cancer. Ann Oncol. 2017;28:2386–98. doi: 10.1093/annonc/mdx304. [DOI] [PubMed] [Google Scholar]
- 24.Gillison ML, Chaturvedi AK, Anderson WF, Fakhry C. Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma. J Clin Oncol. 2015;33:3235–42. doi: 10.1200/JCO.2015.61.6995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Murphy BA, Wulff-Burchfield E, Ghiam M, Bond SM, Deng J. Chronic systemic symptoms in head and neck cancer patients. J Natl Cancer Inst Monogr. 2019;2019:lgz004. doi: 10.1093/jncimonographs/lgz004. [DOI] [PubMed] [Google Scholar]
- 26.Son E, Fuller CD, Gross ND. Head and neck oncologic emergencies. In: Todd K, Thomas C Jr., editors. Oncologic Emergency Medicine. Cham: Springer; 2016. [Google Scholar]
- 27.Cook TM, Woodall N, Frerk C Fourth National Audit Project. Major complications of airway management in the UK: Results of the fourth national audit project of the Royal College of Anaesthetists and the difficult airway society. Part 1: Anaesthesia. Br J Anaesth. 2011;106:617–31. doi: 10.1093/bja/aer058. [DOI] [PubMed] [Google Scholar]
- 28.Patel A, Nouraei SA. Transnasal humidified rapid-insufflation ventilatory exchange (THRIVE): A physiological method of increasing apnoea time in patients with difficult airways. Anaesthesia. 2015;70:323–9. doi: 10.1111/anae.12923. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Badiger S, John M, Fearnley RA, Ahmad I. Optimizing oxygenation and intubation conditions during awake fibre-optic intubation using a high-flow nasal oxygen-delivery system. Br J Anaesth. 2015;115:629–32. doi: 10.1093/bja/aev262. [DOI] [PubMed] [Google Scholar]
- 30.Shah JP. Patterns of cervical lymph node metastasis from squamous carcinomas of the upper aerodigestive tract. Am J Surg. 1990;160:405–9. doi: 10.1016/s0002-9610(05)80554-9. [DOI] [PubMed] [Google Scholar]
- 31.Khalid MB, Ting P, Pai A, Russo JL, Bakst R, Chai RL, et al. Initial presentation of human papillomavirus-related head and neck cancer: A retrospective review. Laryngoscope. 2019;129:877–82. doi: 10.1002/lary.27296. [DOI] [PubMed] [Google Scholar]
- 32.Schappert SM, Burt CW. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 2001-02. Vital Health Stat 13. 2006 Feb;(159):1–66. [PubMed] [Google Scholar]
- 33.Mehanna H, Paleri V, West CM, Nutting C. Head and neck cancer – Part 1: Epidemiology, presentation, and prevention. BMJ. 2010;341:c4684. doi: 10.1136/bmj.c4684. [DOI] [PubMed] [Google Scholar]
- 34.Chan TV. The patient with sore throat. Med Clin North Am. 2010;94:923–43. doi: 10.1016/j.mcna.2010.06.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Pikus L, Levine MS, Yang YX, Rubesin SE, Katzka DA, Laufer I, et al. Videofluoroscopic studies of swallowing dysfunction and the relative risk of pneumonia. AJR Am J Roentgenol. 2003;180:1613–6. doi: 10.2214/ajr.180.6.1801613. [DOI] [PubMed] [Google Scholar]
- 36.Clavé P, Shaker R. Dysphagia: Current reality and scope of the problem. Nat Rev Gastroenterol Hepatol. 2015;12:259–70. doi: 10.1038/nrgastro.2015.49. [DOI] [PubMed] [Google Scholar]
- 37.Takizawa C, Gemmell E, Kenworthy J, Speyer R. A systematic review of the prevalence of oropharyngeal dysphagia in stroke, Parkinson's disease, Alzheimer's Disease, head injury, and pneumonia. Dysphagia. 2016;31:434–41. doi: 10.1007/s00455-016-9695-9. [DOI] [PubMed] [Google Scholar]
- 38.Denaro N, Merlano MC, Russi EG. Dysphagia in head and neck cancer patients: Pretreatment evaluation, predictive factors, and assessment during radio-chemotherapy, recommendations. Clin Exp Otorhinolaryngol. 2013;6:117–26. doi: 10.3342/ceo.2013.6.3.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Baijens LW, Walshe M, Aaltonen LM, Arens C, Cordier R, Cras P, et al. European white paper: Oropharyngeal dysphagia in head and neck cancer. Eur Arch Otorhinolaryngol. 2021;278:577–616. doi: 10.1007/s00405-020-06507-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Talwar B, Donnelly R, Skelly R, Donaldson M. Nutritional management in head and neck cancer: United Kingdom national multidisciplinary guidelines. J Laryngol Otol. 2016;130:S32–40. doi: 10.1017/S0022215116000402. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Mehanna H, Nankivell PC, Moledina J, Travis J. Refeeding syndrome – Awareness, prevention and management. Head Neck Oncol. 2009;1:4. doi: 10.1186/1758-3284-1-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Enoch S, Miller DR, Price PE, Harding KG. Early diagnosis is vital in the management of squamous cell carcinomas associated with chronic non healing ulcers: a case series and review of the literature. Int Wound J. 2004;1:165–75. doi: 10.1111/j.1742-4801.2004.00056.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Rogers SN, Vedpathak SV, Lowe D. Reasons for delayed presentation in oral and oropharyngeal cancer: The patients perspective. Br J Oral Maxillofac Surg. 2011;49:349–53. doi: 10.1016/j.bjoms.2010.06.018. [DOI] [PubMed] [Google Scholar]
- 44.Peguero J, Khanfar A, Mannem S, Willis M, Markowtiz A. Impending carotid blowout syndrome. J Clin Oncol. 2015;33:e97–8. doi: 10.1200/JCO.2013.48.9641. [DOI] [PubMed] [Google Scholar]
- 45.Rimmer J, Giddings CE, Vaz F, Brooks J, Hopper C. Management of vascular complications of head and neck cancer. J Laryngol Otol. 2012;126:111–5. doi: 10.1017/S0022215111002416. [DOI] [PubMed] [Google Scholar]
- 46.Thim T, Krarup NH, Grove EL, Rohde CV, Løfgren B. Initial assessment and treatment with the airway, breathing, circulation, disability, exposure (ABCDE) approach. Int J Gen Med. 2012;5:117–21. doi: 10.2147/IJGM.S28478. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Salwey L, L'Huillier V, Zaid M, Vené Y, Tavernier L, Mauvais O. Neuropathic pain at diagnosis of head and neck squamous cell carcinoma. Eur Ann Otorhinolaryngol Head Neck Dis. 2020;137:377–80. doi: 10.1016/j.anorl.2020.03.004. [DOI] [PubMed] [Google Scholar]
- 48.Williams JE, Peacock J, Gubbay AN, Kuo PY, Ellard R, Gupta R, et al. Routine screening for pain combined with a pain treatment protocol in head and neck cancer: A randomised controlled trial. Br J Anaesth. 2015;115:621–8. doi: 10.1093/bja/aev263. [DOI] [PubMed] [Google Scholar]
- 49.Gill A, Farwell DG, Moore MG. Nutrition and perioperative care for the patient with head and neck cancer. Oral Maxillofac Surg Clin North Am. 2018;30:411–20. doi: 10.1016/j.coms.2018.06.003. [DOI] [PubMed] [Google Scholar]
- 50.Chaplin JM, Morton RP. A prospective, longitudinal study of pain in head and neck cancer patients. Head Neck. 1999;21:531–7. doi: 10.1002/(sici)1097-0347(199909)21:6<531::aid-hed6>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
- 51.Macfarlane TV, Wirth T, Ranasinghe S, Ah-See KW, Renny N, Hurman D. Head and neck cancer pain: Systematic review of prevalence and associated factors. J Oral Maxillofac Res. 2012;3:e1. doi: 10.5037/jomr.2012.3101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.World Health Organization. Geneva: World Health Organization; WHO Guidelines for the Pharmacological and Radiotherapeutic Management of Cancer Pain in Adults and Adolescents. Available from: https://www.who.int/publications/i/item/9789241550390. [Last accessed on 2023 Mar 11] [PubMed] [Google Scholar]
- 53.Ventafridda V, Saita L, Ripamonti C, De Conno F. WHO guidelines for the use of analgesics in cancer pain. Int J Tissue React. 1985;7:93–6. [PubMed] [Google Scholar]
- 54.Kestenbaum MG, Vilches AO, Messersmith S, Connor SR, Fine PG, Murphy B, et al. Alternative routes to oral opioid administration in palliative care: A review and clinical summary. Pain Med. 2014;15:1129–53. doi: 10.1111/pme.12464. [DOI] [PubMed] [Google Scholar]
- 55.Chua KS, Reddy SK, Lee MC, Patt RB. Pain and loss of function in head and neck cancer survivors. J Pain Symptom Manage. 1999;18:193–202. doi: 10.1016/s0885-3924(99)00070-6. [DOI] [PubMed] [Google Scholar]
- 56.Mishra S, Bhatnagar S, Goyal GN, Rana SP, Upadhya SP. A comparative efficacy of amitriptyline, gabapentin, and pregabalin in neuropathic cancer pain: A prospective randomized double-blind placebo-controlled study. Am J Hosp Palliat Care. 2012;29:177–82. doi: 10.1177/1049909111412539. [DOI] [PubMed] [Google Scholar]
- 57.Lee TS, Wang LL, Yi DI, Prasanna PD, Kandl C. Opioid sparing multimodal analgesia treats pain after head and neck microvascular reconstruction. Laryngoscope. 2020;130:1686–91. doi: 10.1002/lary.28402. [DOI] [PubMed] [Google Scholar]
- 58.National Institute for Health and Care Excellence. Head and neck cancers – Recognition and Referral NICE. 2021. Available from: https://cks.nice.org.uk/topics/head-neck-cancers-recognition-referral/ [Last accessed on 2023Mar11] [PubMed]
- 59.Brouha XD, Tromp DM, Koole R, Hordijk GJ, Winnubst JA, de Leeuw JR. Professional delay in head and neck cancer patients: Analysis of the diagnostic pathway. Oral Oncol. 2007;43:551–6. doi: 10.1016/j.oraloncology.2006.06.002. [DOI] [PubMed] [Google Scholar]
- 60.Centre for Biologics Evaluation and Research. Gardasil 9 U.S. Food and Drug Administration. FDA. 2020. Available from: https://www.fda.gov/vaccines-blood-biologics/vaccines/gardasil-9. [Last accessed on 2023Mar11]
- 61.Franceschi S, Bidoli E, Barón AE, Barra S, Talamini R, Serraino D, et al. Nutrition and cancer of the oral cavity and pharynx in North-East Italy. Int J Cancer. 1991;47:20–5. doi: 10.1002/ijc.2910470105. [DOI] [PubMed] [Google Scholar]
- 62.Schlecht NF, Franco EL, Pintos J, Kowalski LP. Effect of smoking cessation and tobacco type on the risk of cancers of the upper aero-digestive tract in Brazil. Epidemiology. 1999;10:412–8. doi: 10.1097/00001648-199907000-00009. [DOI] [PubMed] [Google Scholar]
